Please do not adjust margins
Chemical Science
Page 9 of 12
ARTICLE
DOI: 10.1039/C6SC04899D
Journal Name
reference of CFCl3 for 19F. Coupling constants, J, are given in CD2Cl2, 298 K): δ 165.1 (s, C2-py), 153.5 (s, Co-py-a), 152.7 (s, Co-py-
Hz. Spectral assignments were achieved by combination of 1H- b), 150.8 (s, Ir-CIPr), 148.2 (s, C6-py), 146.6 and 146.4 (both s, Cq-
1H COSY, 13C APT and 1H-13C HSQC/HMBC experiments. C, H, IPr), 145.3 (s, Ir-CPh), 143.6 (s, Cq-Ph), 143.4 (s, Cm2-Ph), 138.0 (s,
and N analyses were carried out in a Perkin-Elmer 2400 Cp-py-a), 137.1 (s, CqN), 137.0 (s, Cp-py-b), 136.8 (s, C4-py), 130.2 (s,
CHNS/O analyser. GC-MS spectra were recorded on a Hewlett- Cp-IPr), 129.5 (s, Cp-Ph), 126.2 (s, Cm-py-a), 125.7 (s, Cm-py-b), 125.6
Packard GC-MS system. Column chromatography was (s, =CHN), 124.4 and 123.7 (both s, Cm-IPr), 123.6 (s, Co-Ph), 123.0
performed using silica gel (70-230 mesh).
(s, C5-py), 121.4 (s, Cm1-Ph), 119.9 (s, C3-py), 29.0 and 28.9 (s,
CHMeIPr), 26.9, 26.2, 21.3, and 20.8 (all, s, CHMeIPr). 19F NMR
(400 NMR, CD2Cl2, 298 K): δ –152.5 (s, BF4). Anal. Calcd. for
C48H55IrN5BF4 (981.41): C, 58.77; H, 5.65; N, 7.14. Found: C,
58.70; H, 5.66; N, 7.16.
Synthesis and Characterisation of Complexes 9 and 13-17.‡
[Ir(H)2(IPr)(py)3][BF4]
(1)
.
A
solution
of
[Ir(COD)(IPr)(acetone)][BF4] (300 mg, 0.36 mmol) in acetone
(10 mL) was reacted with pyridine (0.5 mL) and stirred under a
hydrogen atmosphere (1 bar) for 1 h. The resulting pale yellow
solution was concentrated to ca. 0.5 mL, and treated with
diethyl ether to afford a white solid. The solid was separated
by decantation, washed with diethyl ether, and dried in vacuo.
A CH2Cl2 solution (0.4 mL) of this solid (12 mg) was layered
with diethyl ether (5 mL) and stored into a glove box at room
temperature to afford crystals suitable for X-ray diffraction.
Yield: 72% (234 mg, 0.25 mmol). 1H NMR (300 MHz, CD2Cl2,
263 K): δ 8.14 (d, JH-H = 5.0, 4H, Ho-py-a), 7.84 (d, JH-H = 5.7, 2H,
Ho-py-b), 7.71 (t, JH-H = 7.6, 2H, Hp-py-a), 7.66 (t, JH-H = 7.5, 1H, Hp-
py-b), 7.30 (t, JH-H = 7.7, 2H, Hp-IPr), 7.11 (d, JH-H = 7.7, 4H, Hm-IPr),
7.09 (dd, JH-H = 7.6, 5.0, 4H, Hm-py-a), 7.07 (s, 2H, =CHN), 6.96
(dd, JH-H = 7.5, 5.7, 4H, Hm-py-b), 2.87 (sept, JH-H = 6.9, 4H,
CHMeIPr), 1.16 and 1.11 (both d, JH-H = 6.9, 24H, CHMeIPr), –
22.48 (s, 2H, Ir-H). 13C {1H}-APT NMR plus HSQC and HMBC (75
MHz, CD2Cl2, 298 K): δ 155.3 (s, Co-py-b), 154.7 (s, Ir-CIPr), 153.5
(s, Co-py-a), 145.6 (s, Cq-IPr), 138.1 (s, CqN), 136.8 (s, Cp-py-b), 136.6
(s, Cp-py-a), 129.9 (s, Cp-IPr), 125.9 (s, Cm-py-a), 125.7 (s, Cm-py-b),
123.8 (s, Cm-IPr), 28.9 (s, CHMeIPr), 25.9 and 21.6 (both s,
CHMeIPr). 19F NMR (400 NMR, CD2Cl2, 298 K): δ –155.2 (s, BF4).
Anal. Calcd. for C42H54BF4IrN5 (908.40 + CH2Cl2): C, 52.02; H,
5.69; N, 7.05. Found: C, 51.95; H, 5.85; N, 6.85.
[Ir(H)(IPr)(Thpy-1H)(py)2][BF4] (13). 2-Thienylpyridine (21 mg,
0.13 mmol) was added to a solution of
1 (120 mg, 0.13 mmol)
in 5 mL of dichloromethane and the resulting solution was
stirred for 40 min at room temperature. After this time, the
resulting light yellow solution was concentrated to ca. 0.5 mL
and diethyl ether was added to give a white solid. The solid
thus formed was separated by decantation, washed with
diethyl ether and dried in vacuum. Yield: 67% (87 mg, 0.09
1
mmol). H NMR (400 MHz, CD2Cl2, 283 K): δ 8.27 (d, JH-H = 5.3,
2H, Ho-py-a), 7.92 (t, JH-H = 7.8, 1H, Hp-py-a), 7.63 (dd, JH-H = 7.9,
6.9, 1H, H4-py), 7.49 (t, JH-H = 7.6, 2H, Hp-IPr), 7.48 (d, JH-H = 7.9,
1H, H3-py), 7.47 (t, JH-H = 7.1, 1H, Hp-py-b), 7.30 (dd, JH-H = 7.8, 5.3,
2H, Hm-py-a), 7.29 (d, JH-H = 6.2, 1H, Ho-py-b), 7.25 and 7.13 (both
d, JH-H = 7.6, 4H, Hm-IPr), 7.20 (d, JH-H = 5.5, 1H, H6-py), 7.11 (s, 2H,
=CHN), 6.94 and 5.48 (both d, JH-H = 4.7, 2H, HTh), 6.78 (dd, JH-H
= 7.1, 6.2, 2H, Hm-py-b), 6.66 (dd, JH-H = 6.9, 5.5, 1H, H5-py), 2.86
and 2.28 (both sept, JH-H = 6.9, 4H, CHMeIPr), 1.13, 1.06, 1.05,
and 0.55 (all d, JH-H = 6.9, 24H, CHMeIPr), –19.30 (s, 1H, Ir-H).
13C {1H}-APT NMR plus HSQC and HMBC (100 MHz, CD2Cl2, 298
K): δ 160.9 (s, C2-py), 154.0 (s, Co-py-a), 152.4 (s, Co-py-b), 150.1 (s,
Ir-CIPr), 148.5 (s, Ir-CTh), 148.4 (s, C6-py), 146.6 and 146.2 (both s,
Cq-IPr), 140.0 and 128.0 (both s, CTh), 138.1 (s, Cp-py-a), 137.3 (s,
C4-py), 137.1 (s, CqN), 137.0 (s, Cp-py-b), 136.8 (s, Cq-Th), 130.3 (s,
Cp-IPr), 126.3 (s, Cm-py-a), 125.5 (s, Cm-py-b), 125.4 and 124.3 (both
s, Cm-IPr), 123.8 (s, =CHN), 120.4 (s, C5-py), 119.2 (s, C3-py), 29.1
and 28.9 (s, CHMeIPr), 27.0, 26.3, 21.4, and 20.7 (all, s,
CHMeIPr). 19F NMR (400 NMR, CD2Cl2, 298 K): δ –153.0 (s, BF4).
Anal. Calcd. for C46H53IrN5BF4 (995.40): C, 55.98; H, 5.41; N,
7.10. Found: C, 55.93; H, 5.46; N 7.10.
[Ir(H)(IPr)(Phpy-1H)(py)2][BF4] (9). 2-Phenylpyridine (19 µL,
0.13 mmol) was added to a solution of
1 (120 mg, 0.13 mmol)
in 5 mL of dichloromethane and the resulting solution was
stirred for 40 min at room temperature. After this time, the
resulting light yellow solution was concentrated to ca. 0.5 mL
and diethyl ether was added to give a white solid. The solid
thus formed was separated by decantation, washed with
diethyl ether and dried in vacuum. Yield: 63% (82 mg, 0.08
mmol). A CH2Cl2 solution (0.3 mL) of this solid (10 mg) was
layered with diethyl ether (5 mL) and stored into a glove box at
[Ir(H)(IPr)(py)2(p-tolylpy-1H)][BF4] (14). 2-(p-Tolyl)pyridine (22
mg, 0.13 mmol) was added to a solution of
1 (120 mg, 0.13
mmol) in 5 mL of dichloromethane and the resulting solution
was stirred for 40 min at room temperature. After this time,
the resulting light yellow solution was concentrated to ca. 0.5
mL and diethyl ether was added to give a light yellow solid.
The solid thus formed was separated by decantation, washed
with diethyl ether and dried in vacuum. Yield: 67% (88 mg,
room temperature to afford crystals suitable for X-ray
1
diffraction. H NMR (300 MHz, CD2Cl2, 298 K): δ 8.24 (d, JH-H
=
5.1, 2H, Ho-py-a), 7.92 (t, JH-H = 6.6, 1H, Hp-py-a), 7.91 (d, JH-H = 7.9,
1H, H3-py), 7.72 (dd, JH-H = 7.9, 6.7, 1H, H4-py), 7.55 (d, JH-H = 7.9,
1H, Ho-Ph), 7.49 (t, JH-H = 6.7, 1H, Hp-py-b), 7.47 (t, JH-H = 6.6, 2H,
Hp-IPr), 7.40 (d, JH-H = 5.6, 1H, H6-py), 7.37 (d, JH-H = 6.0, 2H, Ho-py-
b), 7.31 (dd, JH-H = 6.6, 5.1, 2H, Hm-py-a), 7.11 (d, JH-H = 6.6, 4H,
Hm-IPr), 7.09 (s, 2H, =CHN), 6.78 (dd, JH-H = 6.7, 5.6, 1H, H5-py),
6.77 (dd, JH-H = 6.7, 6.0, 2H, Hm-py-b), 6.75 (dd, JH-H = 7.9, 7.7, 1H,
Hm1-Ph), 6.46 (dd, JH-H = 8.2, 7.7, 1H, Hp-Ph), 5.97 (d, JH-H = 8.2,
1H, Hm2-Ph), 2.87 and 2.25 (both sept, JH-H = 6.6, 4H, CHMeIPr),
1.11, 1.05, 1.02, and 0.43 (all d, JH-H = 6.6, CHMeIPr), –18.14 (s,
1H, Ir-H). 13C {1H}-APT NMR plus HSQC and HMBC (75 MHz,
0.09 mmol). 1H NMR (400 MHz, CD2Cl2, 298 K): δ 8.20 (d, JH-H
=
5.1, 2H, Ho-py-a), 7.93 (t, JH-H = 6.9, 1H, Hp-py-a), 7.90 (d, JH-H = 7.6,
1H, H3-py), 7.69 (dd, JH-H = 7.6, 6.9, 1H, H4-py), 7.49 (t, JH-H = 6.9,
1H, Hp-py-b), 7.48 (both t, JH-H = 7.9, 2H, Hp-IPr), 7.46 (d, JH-H = 8.2,
1H, Ho-Ph), 7.36 (br, 2H, Ho-py-b), 7.33 (d, JH-H = 5.8, 1H, H6-py),
7.30 (dd, JH-H = 6.9, 5.1, 2H, Hm-py-a), 7.23 and 7.09 (both d, JH-H
= 7.9, 4H, Hm-IPr), 7.22 (s, 2H, =CHN), 6.79 (dd, JH-H = 6.9, 5.3,
2H, Hm-py-b), 6.71 (dd, JH-H = 6.9, 5.8, 1H, H5-py), 6.58 (d, JH-H
=
8.2, 1H, Hm1-Ph), 5.75 (s, 1H, Hm2-Ph), 2.91 and 2.20 (both br, 4H,
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins